# Phase II Trial of Radical Pleurectomy With or Without Intraoperative PDT for Malignant Pleural Mesothelioma

> **NCT02153229** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 52 (actual)

## Conditions studied

- Epitheliod Malignant Pleural Mesothelioma

## Interventions

- **RADIATION:** Photodynamic Therapy
- **PROCEDURE:** Radical Pleurectomy
- **RADIATION:** Chemotherapy
- **DRUG:** Photofrin 2.0 mg/kg

## Key facts

- **NCT ID:** NCT02153229
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2014-06-02
- **Primary completion:** 2026-12-16
- **Final completion:** 2027-12
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2025-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02153229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02153229, "Phase II Trial of Radical Pleurectomy With or Without Intraoperative PDT for Malignant Pleural Mesothelioma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02153229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*